For private equity firms, independent sponsors, investment banks, and acquisition entrepreneurs evaluating healthcare targets. Deals disappoint when clinical and operational risk goes unseen in diligence; we assess the realities that decide whether the thesis holds and whether the value is there to create.
Financial diligence tells you what happened. These tell you whether it continues.
Engagements are scoped to the deal. We discuss the mandate before quoting; no fixed universal price.
Before you spend diligence budget on a target.
Full diligence on a healthcare target.
When the question is demand, positioning, and service-line economics.
For an asset underperforming the value-creation plan.
Where a mandate needs a full financial quality-of-earnings analysis, complex regulatory review, or specialty expertise beyond our team, we scope it with qualified partners and say so up front.
We'll outline where a clinically informed read changes the diligence, and the price.
Book a Free 30-Minute Consultation →